Royalty Pharma announced the appointment of Molly Sawaya as Executive Vice President, EVP, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experience, responsible for designing and delivering the firm’s Human Resources agenda, including onboarding, colleague engagement, professional development, compensation and benefits.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPRX:
- Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
- Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
- Royalty Pharma Declares Third Quarter 2024 Dividend
- Royalty Pharma price target raised to $51 from $48 at Morgan Stanley
- Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference